90Y-MAb 92-13

N/A

Report date: 2025/11/12 17:54:39

Base Information

Drug Name90Y-MAb 92-13

Drug Alias NameYttrium-90 ((90)Y)-MAb 92-13(90)Y-MAb 92-13

ClassificationRadiation-emitting products > Nuclides > Yttrium > 90YRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionAnti-FZD10

TargetsFrizzled-10

Therapy Area/IndicationsSarcoma, Synovial

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Tokyo

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Tokyo

Inactive CompaniesN/A

Active IndicationsSarcoma, Synovial

Inactive IndicationsN/A

Other Information

ATC CodeN/A